[Effectiveness of the association of prednisone, vincristine, methyl-glyoxal-bis(guanylhydrazone)(methyl-GAG) and methotrexate in monoblastic acute leukemia].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014750:Vincristine; D011241:Prednisone; D008727:Methotrexate
Essai de recherche d'efficacité de l'association de prednisone, vincristine, méthyl-glyoxal-bis (guanylhydrazone) (méthyl-GAG) et méthotrexate sur les leucémies aiguës monoblastiques.